Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Publisher Correction: SARS-CoV-2 and HIV-1 — a tale of two vaccines

The Original Article was published on 16 July 2021

Correction to: Nature Reviews Immunology https://doi.org/10.1038/s41577-021-00589-w, published online 16 July 2021.

The sentence “Like SARS-CoV-2-neutralizing antibodies, HIV-1 non-neutralizing antibodies are easily induced by any of a number of HIV-1 Env monomers or open trimerics” should read “Like SARS-CoV-2-neutralizing antibodies, HIV-1 non-neutralizing antibodies are easily induced by any of a number of HIV-1 Env monomers or open trimers”. This correction was missed during the proofing process and has now been corrected in the HTML and PDF versions of the article in order to ensure correct scientific terminology.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Barton F. Haynes.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Haynes, B.F. Publisher Correction: SARS-CoV-2 and HIV-1 — a tale of two vaccines. Nat Rev Immunol 21, 612 (2021). https://doi.org/10.1038/s41577-021-00604-0

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing